Virtual Reality relaxation for self-management of stress in patients with psychiatric symptoms - a randomized cross-over pilot study

Virtual Reality relaxation for self-management of stress in patients with psychiatric symptoms - a randomized cross-over pilot study - VRelax for reducing stress

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON46448

Enrollment

Registered

2018-02-26

Start date

2018-02-01

Completion date

Unknown

Last updated

2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

anxiety depression psychosis

Interventions

- VRelax: the tool is used with a smartphone that is connected to a head mounted display. When activated, the participant is on a beach, from which he/she can choose where to go. The 360o videos of

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: • Currently receiving ambulatory treatment for DSM-5 depressive disorder, bipolar disorder, anxiety disorder or psychotic disorder • At least moderate level of perceived stress, based on self-report or clinician report • Age >18

Exclusion criteria

Exclusion criteria: • DSM-5 diagnosis of substance use disorder • Benzodiazepine use > 10 mg / day diazepam equivalent • Diagnosis of epilepsy or organic brain damage • Insufficient command of Dutch language

Design outcomes

Primary

Measure	Time frame
Primary outcomes: momentary subjective stress, user experiences.	—

Secondary

Measure	Time frame
Secondary outcomes: perceived stress, psychiatric symptoms, use of benzodiazepines and psychoactive substances.	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)